Type 1 diabetes Flashcards
Epidemiology
Prevalence 0.5%
Peak onset adolescence
- 6/12 to 80
M=F
white caucasian
Seasonal variability
More prevalent northern latitudes
Genetic predisposition
0.5% background risk
1-2% if mother affected
3-6% if father affected
6% if sibling has affected
36% if monozygotic twin affected
Genetic predisposition
Association with HLA antigens:
HLA DR3-DQ2 and DR4-DQ8 predispose
90% of Scandinavians with type 1 diabetes positive for 1 or both
Pathophysiology
Beta cell events trigger autoimmune response
Antibodies to insulin or GAD generally appear first
Other beta cell antibodies follow
- IA2, Zn2+ transporter 8
Selective immune beta cell destruction
Autoimmune trigger
Viral infection (Coxsackie)
ER stress
Cytokines
Associations with type 1 diabetes
Coeliac disease
Hypothyroidism
Grave’s disease
Addison’s disease
Hypogonadism
Pernicious anaemia
Vitiligo
Autoimmune polyglandular syndromes
Symptoms
Lethargy
Polyuria
Polydipsia
Blurred vision
Candida infections
Weight loss
Ketosis/ ketoacidosis
Death
Diagnosis of type 1 diabetes
Age of onset
Rapidity of onset
Phenotype
PMH
FH
Weight loss
Ketosis
GAD? IA2? Zn2+ transporter 8 antibody positive
C peptide
C peptide
Produced in 1:1 molar ratio with insulin
Need adequate stimulus for secretion
Insulin
Necessary for survival
Peptide hormone needs to be given parenterally
- subcutaneous
- inhaled
- mucous membranes
Various types
- primary structure (animal, human, analogue)
- duration of action (addition of protamine, altered solubility, fatty acid chain)
- strength
Typical insulin regimen
Basal bolus regimen
- rapid acting insulin pre meal (bolus)
- long acting background insulin (basal)
Balanced regimen
Rapid acting insulin reflects CHO intake
Factors affecting blood glucose
Diet
Injection site
Temperature
Exercise
Illness
Stress
Alcohol
Menstrual cycle
Hypoglycaemia autonomic symptoms
Palpitations
Sweating
Tremor
Hypoglycaemia neuroglycopaenic symptoms
Confusion
Transplantation
Pancreas
- almost always SPK or PAK
Islet cell
- edmonton protocol
- UK islet cell programme